Tirelizumab in Combination With Chemoradiation in Patients With

Updated 05/10/2024

Status Recruiting

Clinical Trial Summary

To evaluate the efficacy and safety of chemoradiotherapy combined with tirelizumab in the treatment of initial unresectable locally advanced gastric cancer or gastroesophageal junction cancer.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05528367
Study type	Interventional
Source	Zhejiang Cancer Hospital
Contact	Liu Lu ying, MD
Phone	0571-88128142
Email	luyingliu@163.com
Status	Recruiting
Phase	Phase 2
Start date	January 1, 2022
Completion date	December 31, 2024

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT05545436` - Carrelizumab (PD-1) Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer	Phase 2
	Not yet recruiting	`NCT05524974` - Clinical Study of Camrelizumab, Apatinib Mesylate and Nab-paclitaxel Combined With Oxplatin and S-1 in the Neoadjuvant Treatment of Locally Advanced Gastric Cancer With Different Genotypes	Phase 2
	Active, not recruiting	`NCT03192735` - Apatinib Combined With SOX Neoadjuvant Therapy for Locally Advanced Gastric Cancer	Phase 2
	Recruiting	`NCT03961373` - Standard Versus Super-extended Lymphadenectomy After Neo-adjuvant Chemotherapy for Gastric Cancer	Phase 3
	Completed	`NCT02192983` - A Comparison of XELOX Regimen and EOX Regimen as Neoadjuvant Chemotherapy Regimen for Locally Advanced Gastric Cancer.	N/A
	Not yet recruiting	`NCT05610332` - Clinical Efficacy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer With Different Immunotypes	Phase 3
	Recruiting	`NCT02855788` - Metronomic Chemotherapy in Advanced Gastric Cancer	Phase 2
	Not yet recruiting	`NCT02365896` - Comparison of Short Term Outcomes Between Totally Laparoscopic and Laparoscopy-Assisted Distal Gastrectomy With Billroth-II Reconstruction and D2 Lymphadenectomy for Locally Advanced Gastric Cancer	N/A
	Recruiting	`NCT05141747` - A Study of MRG002 in the Treatment of HER2-positive/HER2-low Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer.	Phase 2
	Active, not recruiting	`NCT06277453` - Effect of Adjuvant Chemotherapy Cycles on Patients With Node-negative Gastric Cancer Following Neoadjuvant Chemotherapy
	Recruiting	`NCT04792515` - Camrelizumab Combined With SOX and/or Apatinib for Locally Advanced Gastric Cancer	Phase 2
	Active, not recruiting	`NCT06235164` - The Safety and Efficacy of Neoadjuvant Immunochemotherapy Followed by Laparoscopic Gastrectomy for Gastric Cancer
	Recruiting	`NCT03322969` - Receiving Modified Chemotherapy Followed With Radical Resection After Neoadjuvant Chemotherapy	Phase 2
	Recruiting	`NCT02302794` - A Multicenter Clinical Trial on Laparoscopic Gastric Cancer Surgery Compared With Open Surgery	Phase 3